Date | Insider | Price | Amount |
---|---|---|---|
12-22-2023 Insider Buy |
Kelly T. McKee Jr. Chief Medical Officer |
$0.36 CAGR » |
$2,499.84 6,944 shares |
9-25-2023 Insider Buy |
Kelly T. McKee Jr. Chief Medical Officer |
$0.52 CAGR » |
$5,019.56 9,653 shares |
8-25-2023 Insider Buy |
David A. Dodd President, CEO |
$0.57 CAGR » |
$19,999.59 35,087 shares |
8-18-2023 Insider Buy |
Mark Reynolds CFO |
$0.52 CAGR » |
$5,179.00 10,000 shares |
4-24-2023 Insider Buy |
David A. Dodd President, CEO |
$0.64 CAGR » |
$20,444.80 32,000 shares |
4-20-2023 Insider Buy |
Mark Reynolds CFO |
$0.63 CAGR » |
$5,040.00 8,000 shares |
9-21-2022 Insider Buy |
Randal D. Chase Director |
$1.10 CAGR » |
$11,000.00 10,000 shares |
6-27-2022 Insider Buy |
Kelly T. McKee Jr. Chief Medical Officer |
$1.12 CAGR » |
$4,999.68 4,464 shares |
6-21-2022 Insider Buy |
Randal D. Chase Director |
$1.21 CAGR » |
$12,100.00 10,000 shares |
5-5-2022 Insider Buy |
Kelly T. McKee Jr. Chief Medical Officer |
$0.72 CAGR » |
$6,999.84 9,722 shares |
9-29-2020 Insider Buy |
Randal D. Chase Director |
$5.00 CAGR » |
$83,065.00 16,613 shares |
9-29-2020 Insider Buy |
Dean G. Kollintzas Director |
$5.00 CAGR » |
$59,935.00 11,987 shares |
9-29-2020 Insider Buy |
John N. Spencer Jr. Director |
$5.00 CAGR » |
$105,120.00 21,024 shares |
9-29-2020 Insider Buy |
Robert T. McNally Director |
$5.00 CAGR » |
$269,625.00 53,925 shares |
9-29-2020 Insider Buy |
David A. Dodd President, CEO |
$5.00 CAGR » |
$409,350.00 81,870 shares |
9-29-2020 Insider Buy |
Mark Reynolds CFO |
$5.00 CAGR » |
$300,920.00 60,184 shares |
5-5-2015 Insider Buy |
Randal D. Chase Director |
$0.19 CAGR » |
$1,899.50 10,000 shares |
4-23-2015 Insider Buy |
Mark Reynolds CFO |
$0.17 CAGR » |
$5,215.00 30,000 shares |
4-20-2015 Insider Buy |
Randal D. Chase Director |
$0.17 CAGR » |
$5,100.00 30,000 shares |
4-20-2015 Insider Buy |
John N. Spencer Jr. Director |
$0.17 CAGR » |
$3,015.00 18,000 shares |
1-31-2012 Insider Buy |
Mark Reynolds CFO |
$0.67 CAGR » |
$10,050.00 15,000 shares |
1-16-2012 Insider Buy |
Steven S. Antebi Director |
$0.67 CAGR » |
$20,100.00 30,000 shares |
12-30-2011 Insider Buy |
Mark Reynolds CFO |
$0.67 CAGR » |
$10,050.00 15,000 shares |
12-30-2011 Insider Buy |
Robert T. McNally President/CEO |
$0.67 CAGR » |
$19,999.50 29,850 shares |
12-30-2011 Insider Buy |
Harriet L. Robinson Chief Scientific Officer |
$0.67 CAGR » |
$100,000.18 149,254 shares |
12-30-2011 Insider Buy |
David A. Dodd Director |
$0.67 CAGR » |
$75,040.00 112,000 shares |
12-30-2011 Insider Buy |
Dean G. Kollintzas Director |
$0.67 CAGR » |
$9,999.75 14,925 shares |
12-30-2011 Insider Buy |
John N. Spencer Jr. Director |
$0.67 CAGR » |
$9,999.75 14,925 shares |
Also See: Institutional Holders of GOVX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/26/2023 | |
End date: | 04/30/2024 | |
Start price/share: | $5.48 | |
End price/share: | $1.40 | |
Dividends collected/share: | $0.00 | |
Total return: | -74.45% | |
Annualized Gain: | -217.40% | |
Starting investment: | $10,000.00 | |
Ending investment: | $2,555.00 | |
Years: | 0.34 |
GeoVax Labs Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent GeoVax Labs insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GOVX
Free GOVX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the GeoVax Labs Insider Buying occurred are:
CNS Pharmaceuticals Insider Buying |